2010 was a busy year for the inpatient ward, which had a capacity utilization rate of over 100%. As of January 2011, the cumulative number of patients was 7207, the average capacity utilization rate was 107.1% and the average stay was 19.2 days. As of March, the ward has not gotten any less busy. It seems that the final utilization rate will be around the usual 110%. A breakdown by condition (table below) shows an overwhelming number of patients with melanomas. In addition to new patients with melanomas, the ward had many patients who came for regular stays for chemotherapy. The second greatest number was for SCC, followed by psoriatic arthritis, which seemed to be the result of the approval of Infliximab. Many patients stayed for regular IV administration of Infliximab. Overall, there seemed to be as many neoplastic cases as inflammatory cases.

Many institutions referred patients during FY 2010, as usual: In February, patients referred by 78 institutions accounted for 68% of the inpatients. I would like to extend
my gratitude to the referring institutions.